ABSIRACT We have found that poly(L-lysine) can be a very effective agent in preventing the growth of Ehrlich ascites tumors in mice. When given optimal doses of poly(L-lysine) (Mr 60 X 103) intraperitoneally for 5 consecutive days, beginning on day 1 after inoculation with Ehrlich ascites cells, White Swiss mice show nearly a 100% remission from subsequent tumor growth. Rechallenge of "cured" animals with tumor cells, however, shows no long-term immunological protection. In tissue culture, poly(L-lysine) shows a related potent cytotoxicity with HeLa cells; interestingly, the D isomer has properties strikingly different from those of the L isomer. In addition, there is a strong molecular weight dependence in that the small polylysine (Mr 3 X 103) possess less than 1/20th the cytotoxicity of large polymers (Mr 70 X 103) on a weight basis in both cell culture and animal studies. At the same time, none of these lysine polymers gives any significant increase in life span to BDF1 mice infected with L1210 murine leukemia cells. We have also further explored the mechanism by which the polylysines express their cytotoxicity. These data indicate that lysine polymers show cell specificity in their action and in some cases they may be beneficial as potent antineoplastic agents, particularly when molecular weight is taken into consideration. For more than 25 years, poly(L-lysine) has been known to have unusual biological properties. Early studies showed that it decreased the infectivity of tobacco mosaic virus (1), disturbed thrombin formation in rats (2), blocked the development of bacteriophage (3, 4), protected chicken embryos from animal viruses (5, 6), and possessed antibacterial activity (7). There was also an early report that indicated that polylysine had some activity against murine tumors (8). More recently, polylysine has been found to exhibit a large number of unique membrane properties. These include the ability to enhance the cellular uptake of macromolecules (9), to inhibit iodide uptake by thyroid slices (10), to produce pathogenesis of the glomerular epithelium (11), to act as an anticholinesterase (12), to specifically agglutinate the lymphocytes from cancer patients (13), and to either increase or decrease the transport of specific radioisotopes into cells (14) . These effects are probably associated with the polycationic character of polylysine and are probably due to specific interactions on the cell membrane.
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Recently, we have been examining the ability of polylysine to serve as an efficient drug carrier (15) . In doing the controls for these studies, we found that poly(L-lysitie)s of a certain Mr, (60 X 103) could induce 100% remissions in mice inoculated with Ehrlich ascites when the polymer was administered at increased doses. This paper presents results on the antineoplastic activity and toxicity as functions of polymer molecular weight and concentration. Also, we will provide further information into the mechanism accounting for the antineoplastic and cytotoxic activities of polylysine.
MATERIALS AND METHODS
Poly(L-lysine) hydrobromide (Mrs 3,000, 13,000, 35,000, 60,000, and 70,000) and poly(D-lysine) (Mrs 36,000 and 70,000) were purchased from Sigma and were used without further purification. Standard solutions of polylysine were prepared by weighing the dry lyophilized material and dissolving it in the necessary amount of phosphate-buffered saline or distilled water.
Animal Testing. Mice of the strain indicated (see figure and table legends) were inoculated intraperitoneally with 0.1 ml of either L1210 murine leukemia cells (105 cells per animal) or Ehrlich ascites carcinoma (2-10 X 106 cells per animal) on day 0. Beginning on day 1, injections were given intraperitoneally for 5 consecutive days with the appropriate polylysine solution in approximately 0.1 ml. Subsequently, the animals were monitored for death as a result of tumor growth. Treated animals showing an increase in life-span of more than 300% in comparison to untreated controls were considered to be free of tumor due to treatment and the experiment was discontinued.
Toxicity Testing. Toxicity studies of polylysine in mice were carried out as indicated above with the exception that the mice received no tumor inoculation and they were subsequently monitored for death due to polylysine toxicity instead of tumor. 
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Thymidine Incorporation Assay. Experiments were started by replacing the medium with medium containing [6-3H]-thymidine (New England Nuclear) and an appropriate amount of polylysine. At the times indicated, duplicate plates were removed from the incubator, aspirated, and washed twice with Na/K/Pi. Free thymidine was extracted with cold 5% trichloroacetic acid for 15 min followed by a wash with the same solution. The remaining DNA and cell debris was then solubilized with 2 ml of 0.1% NaOH; 0.6 ml of this solution was taken for assay in 5 ml of Scintiverse (Fisher) with a Beckman model LS 230 scintillation counter.
RESULTS AND DISCUSSION
Poly(L-lysine) of Mr 60 X 103 showed a marked concentration-dependent cytotoxicity to HeLa cells in culture (Fig. 1B) as well as a dramatic antineoplastic effect against Ehrlich ascites carcinoma in White Swiss mice (Table 1 ). These results indicate that polylysine is cytotoxic, but it has some selective properties because at intermediate concentrations it can produce remission from Ehrlich ascites without producing gross toxicity. These results raise a question as to the degree of toxicity of polylysine at yet higher concentrations and the molecular weight dependence associated with toxicity. Fig. 1A shows the toxic effect of polylysine of different Mrs on the growth of HeLa cells in culture; Table 2 shows the approximate 50% lethal dose (LD50) of polylysine of various Mrs in athymic mice. The higher Mr polymers were very toxic to animals and to HeLa cells in culture. In both systems, however, these effects were progressively decreased as the Mr of the polymer decreased. The fact that the smaller polymers had less activity in these cases suggests that there may be a similar correlation between Mr and the antineoplastic activity of polylysine as well. Table 3 shows the ability of polylysine at different Mrs, but at the same concentration, to act as an effective antineoplastic agent against Ehrlich ascites carcinoma in mice. It is clear from these data that there is also a striking correlation between Mr and antineoplastic activity.
It should be pointed out that this antineoplastic activity ap- White Swiss mice were given 2 X 106 Ehrlich ascites cells intraperitoneally on day 0. Beginning on day 1, the mice were given Mr 60 X 103 poly(L-lysine) intraperitoneally in the amounts indicated, for 5 consecutive days.
pears to be selective. In similar experiments with L1210 leukemia in BDF1 mice (data not shown), no antineoplastic activity was observed; there was toxicity only at high doses of polylysine.
These data raise the immediate question of the nature of both the toxicity and the antineoplastic activity of polylysine. In the case of the cytotoxicity with HeLa cells in culture, polylysine must be interacting directly with the HeLa cell. However, the antineoplastic activity could result from either a direct effect on the Ehrlich ascites cells themselves or indirectly by potentiating an immune mechanism responsible for suppressing the growth of Ehrlich ascites cells within the mouse. In order to test the likelihood of a long-term beneficial immune stimulation, we reinoculated mice that had previously survived Ehrlich ascites carcinoma by virtue of polylysine therapy. Six mice rechallenged with 4 X 106 Ehrlich ascites cells died with a median life-span of 22 days and five inoculated controls died with a median life-span of 24 days. These results indicate that no long-term immunological benefit is imparted by previous polylysine treatment. Because polylysine does not appear to promote any long-term immunologic benefit to these animals, the likelihood is increased that the antineoplastic activity arises from direct interaction between the polymer and the cancer cell. However, the possibility that polylysine facilitates a short-term immune response cannot be ruled out. ,jg/ml, 70-80% of the cells remained viable with respect to controls. It should be pointed out that these estimates are a conservative measurement of the number of cells viable after poly(L-lysine) treatment. This is due to the fact that the ratio of polylysine to cells in the cloning experiments was by necessity 100 times greater than in the thymidine uptake measurements. Moreover, as the polylysine per cells ratio goes up, we have found that polylysine cytotoxicity increases. The important point, however, is that with treatment with poly(L-lysine) at 20 ,ug/ml, a minimum 70% of the cells remained viable even though their DNA, RNA, and protein synthesis had been stopped forseveral hours. Cloning experiments showed no such recovery of viability when poly(D-lysine) was used.
In addition to these results, we found that polylysine had a number of other effects on HeLa cells in culture. Histologically, at polylysine concentrations that did not greatly affect subsequent cell viability, the cells became enlarged and rounded and then showed an increased granulation. At higher concentrations of polylysine the cells were lysed and their components covered the surface of the plate as diffuse crenated discs. Under these conditions, the cells were not viable.
We also found that the effect of polylysine on cells in culture is inversely related to volume. This suggests that, at a fixed concentration of polylysine and number of plated cells, cell viability decreases as the volume of polylysine and medium above the cells increases. This observation indicates that polylysine has a high affinity for plated HeLa cells and that the larger volumes provide more polylysine for binding.
Evidence for high-affinity binding is also provided by our observation that approximately 80% of the short-term cytotoxic activity of polylysine is expressed even when the HeLa cells are washed thoroughly with fresh medium 15 min after treatment with polylysine. This suggests that, once bound, polylysine is not easily removed or that polylysine is capable of producing a membrane perturbation, the effects of which are not dependent upon its subsequent presence.
The present findings provide evidence that poly(L-lysine) has profound cytotoxic effects. In addition, with particular tumor types-namely, Ehrlich ascites carcinoma-polylysine is very effective in preventing tumor growth in mice.
The cytotoxic information we have obtained in culture is particularly interesting when compared to the previous data obtained by others. In this regard the striking concentration effects we observed for the toxicity of polylysine to HeLa cells in culture, the antineoplastic activity of polylysine with Ehrlich ascites tumors in mice, and the toxicity to mice correlate well with the concentration effects seen by others. Ryser (9) found that the ability of poly(L-lysine) and poly(D-lysine) to enhance the uptake of albumin into cells increased linearly with concentration. At the same time, Mayhew and coworkers (17) found that increasing molecular weights of polylysine increasingly promoted the leakage of potassium from Ehrlich ascites tumor cells. These effects appear to be primarily a result of an increased ability of large polymers to perturb cell surfaces and are not simply a result of increased binding. Studies conducted by Mayhew et al. (17) in which the binding of Mr 2800, 16,400, and 120,000 fluorescein-labeled polylysine was monitored showed that the different polymers were bound to a similar extent with increasing concentration.
The differential effects we see for the D and L isomers at short periods of incubation do not correlate with those found by Ryser (9) . Our studies indicate that initially the L isomer is much more effective at preventing cell growth than is the D isomer. In Ryser's studies, on the other hand, the D isomer was an order of magnitude better than the L isomer at promoting the uptake of albumin in 2 hr. These results are not necessarily in disagreement, however, because the mechanism by which polylysine expresses its toxicity (or antineoplastic effect) may not be directly related to its ability to enhance the uptake of macromolecules. The ability of polylysine to inhibit the growth of cells is likely related to its ability to increase the efflux of small molecules from the cell which are required for DNA, RNA, and protein synthesis. For example, in addition to the increased efflux of potassium, it was found that polylysine promotes the leakage of inorganic phosphate, carbohydrates, free amino acids, small peptides, and adenosine 5'-monophosphate into the supernatant (16) . Recently, the ability of a related polyeation, poly(L-ornithine), to inhibit the growth of mouse L cells has been correlated in part to the leakage of potassium from the cells (18) .
The very recent studies by Shier et al. (19) show that poly(L-lysine), as well as other polycations such as poly(L-ornithine) and poly(L-arginine), can activate membrane phospholipase A2 in 3T3-4a Swiss mouse fibroblasts. This finding provides an intriguing mechanism by which polylysine may affect membrane permeability to small molecules by promoting the hydrolysis of membrane phospholipid.
Curiously, Shier (21) , and it has been found that transformed cells are specifically aggregated by this polymer (22) . However, polyanions such as dextran sulfate (23) show some related effects with Ehrlich ascites cells in culture, suggesting that features other than positive charge play a role in these activities. Resolution of all the factors responsible for these unique properties requires further studies with charged and uncharged polymers.
The potent effects of polylysine must be considered when it is used as a drug carrier. However, from studies conducted by Ryser and Shen with methotrexate-polylysine (24) and by us on methotrexate-polylysine (unpublished data) and 6-aminonicotinamide succinate polylysine (15) , it is clear that polylysine has good potential as a drug carrier because drug conjugates with polylysine have more activity than does polylysine alone. Furthermore, from the present study it is likely that the low Mr polymers will be of particular value because they have limited toxicity.
